VETIRA

VETIRA is indicated as monotherapy for the treatment of partial-onset seizures with or without secondary generalization in patients from 16 years of age with newly diagnosed epilepsy. VETIRA is indicated in combination: - in the treatment of partial-onset seizures with or without secondary generalization in adults, children and infants from 1 month of age with epilepsy - in the treatment of myoclonic seizures in adults and adolescents from 12 years old with juvenile myoclonic epilepsy. - in the treatment of primary generalized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalized epilepsy.